insights_auto
Bakit tumaas ang DRUG 8.25%?
Tingnan ang Higit pang Detalyechevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
CA$76.86
arrow_upward
+8.25%(+5.86) 1D
Okt 15, 10:11:47 AM GMT-4 · CAD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa DRUG...
Buksan
CA$74.89
Mataas
CA$76.86
Mababa
CA$73.86
Mkt. cap
758.15M
Avg. na dami
868.00
Dami
503.00
Mataas nang 52-wk
CA$170.00
Mababa nang 52-wk
CA$68.02
EPS
-CA$2.90
Bilang ng mga empleyado
26
Buksan
CA$74.89
Mataas
CA$76.86
Mababa
CA$73.86
Mkt. cap
758.15M
Avg. na dami
868.00
Dami
503.00
Mataas nang 52-wk
CA$170.00
Mababa nang 52-wk
CA$68.02
EPS
-CA$2.90
Bilang ng mga empleyado
26
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketBeat
·
1 araw ang nakalipas
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Tungkol sa Bright Minds Biosciences Inc